Healthcare & Life Sciences
Cabaletta Bio
United Statescabalettabio.com
Cabaletta Bio is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 2 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
2
Investors
About Cabaletta Bio
Cabaletta Bio is a company headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Cabaletta Bio is a clinical-stage biotechnology company developing engineered T cell therapies based on its CABA® platform to treat and potentially cure patients with autoimmune diseases such as lupus, myositis, systemic sclerosis, and pemphigus vulgaris.
Explore Cabaletta Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.